Several Methods for Early Diagnosis of Alzheimer’s Disease Developed

ScienceDaily (June 15, 2011) — PredictAD is an EU-funded research project that develops objective and efficient methods for enabling earlier diagnosis of Alzheimer’s disease. Diagnosis requires a holistic view of the patient combining information from several sources, such as, clinical tests, imaging and blood samples.

“The aim of the PredictAD project is to develop an objective indicator to diagnose Alzheimer’s disease at the earliest stage possible. Current diagnostic guidelines emphasise the importance of various biomarkers in diagnostics. We have developed novel approaches to extract biomarkers from imaging data, electrophysiological data and blood samples, and a unique and clinically useful software tool for integrating all these heterogeneous measurements.” says the Scientific Coordinator of the project, Dr Jyrki Lötjönen from VTT Technical Research Centre of Finland.

Magnetic resonance imaging for identifying atrophy

 

Atrophy in the mediotemporal lobe is a well-known hallmark of Alzheimer’s disease. Magnetic resonance imaging is an excellent tool for measuring this tissue loss. In current clinical practice, images are interpreted mostly only by visual inspection but there is a great need for objective measurements.

PredictAD has developed several methods to meet this need. “We have managed to develop efficient tools for measuring the size of the hippocampus, the atrophy rate of the hippocampus, and two modern approaches based on comparing patient data with previously diagnosed cases available in large databases.” says the leader of the imaging biomarkers work-package, professor Daniel Rueckert from Imperial College London. Positron emission tomography (PET) imaging is another imaging technology studied in the project. A novel tracer developed recently especially for diagnostics of Alzheimer’s disease provides promises for very early diagnosis of the disease.

Detecting changes in the electrophysiology of the brain

 

Alzheimer’s disease is known to affect the electromagnetic activity of the brain. In PredictAD, we have studied the performance of a novel technology, transcranial magnetic stimulation (TMS) combined with electroencephalographic (EEG) measures in detecting the disease. The strength of TMS/EEG is that it allows direct and non-invasive perturbation of the human cerebral cortex without requiring the subject’s collaboration. Our study has shown significant changes in Alzheimer’s patients compared with healthy aging people.

Non-invasive techniques to find biomarkers of the disease

 

Molecular level biomarkers are currently under extensive studies in Alzheimer’s research. Many biomarkers, such as tau proteins and b-amyloid 42, measured from the cerebrospinal fluid (CSF), the liquid surrounding the cerebral cortex, have been found to be strongly related with the disease. One major challenge of these biomarkers is that taking samples from CSF is an invasive measurement limiting their usability in early diagnostics. Blood samples would be an excellent source for detecting Alzheimer’s disease as blood sampling is not considered an invasive technique. PredictAD has studied the role of metabolomic and protein compounds in Alzheimer’s disease from blood samples. The preliminary results reveal several promising compounds.

Methodology for measuring the state of the patient

 

Currently, clinicians make the final diagnosis by combining heterogeneous measurements with information from interviews of the patient and relatives. This process involves subjective reasoning and requires strong expertise from the clinicians. Modern hospitals have huge data reserves containing hidden information that could be utilised in diagnostics by systematic mathematical modelling.

PredictAD has designed a totally novel approach for measuring objectively the state of the patient. This decision support system, developed in close collaboration with clinicians, compares patient measurements with measurements of other patients in large databases and provides at the end an index and graphical representation reflecting the state of the patient. “The PredictAD tool provides a new option to support decision making,” says Prof. Hilkka Soininen from the University of Eastern Finland, leading the clinical validation of the project.

Possibilities for significant savings in health costs

 

Prof. Gunhild Waldemar from Copenhagen University Hospital, Rigshospitalet emphasises the importance of the Alzheimer’s disease research: “Successful, early diagnostics combined with the novel drugs under development and early psychosocial care may delay the institutionalisation of patients, reducing suffering and the costs to the society. It has been calculated that delaying the onset of the disease by five years would halve all costs of Alzheimer’s disease and delaying onset and progression by only one year would reduce the number of Alzheimer’s cases by about 10%.”

Read more http://www.sciencedaily.com/releases/2011/06/110615062000.htm

Share

Posted: June 16th, 2011 under Uncategorized.

Write a comment





RSS Medical Imaging News

  • Noninvasive detection, diagnosis of oral cancer May 23, 2013
    More effective detection and diagnosis of oral cancer could result from an advance in noninvasive imaging of epithelial tissue. The research is thought to have the potential to change the way doctors look for precancerous and cancerous areas in a patient’s mouth. […]
  • MRI-based measurement helps predict vascular disease in the brain May 23, 2013
    Aortic arch pulse wave velocity, a measure of arterial stiffness, is a strong independent predictor of disease of the vessels that supply blood to the brain, according to a new study. […]
  • CT detects twice as many lung cancers as X-ray May 22, 2013
    CT scans detected twice as many early-stage lung cancers as chest X-ray on initial screening exam, according to new results. Investigators say the 20 percent lung cancer mortality reduction previously reported in the NLST is achievable at screening centers in the U.S. […]
  • Addiction as a disorder of decision-making May 22, 2013
    New research shows that craving drugs such as nicotine can be visualized in specific regions of the brain that are implicated in determining the value of actions, in planning actions and in motivation. Researchers suggest abnormal interactions between these decision-making brain regions could underlie addiction. […]
  • Small cancer risk following CT scans in childhood and adolescence confirmed May 21, 2013
    Young people who undergo CT scans are 24 percent more likely to develop cancer compared with those who do not, a study published today on bmj.com suggests. However the absolute excess for all cancers combined was low, at 9.38 for every 100,000 person years of follow-up. […]
  • Elusive search for biomarkers in Huntington's disease May 20, 2013
    While Huntington's disease (HD) is currently incurable, the HD research community anticipates that new disease-modifying therapies in development may slow or minimize disease progression. The success of HD research depends upon the identification of reliable and sensitive biomarkers to track disease and evaluate therapies, and these biomarkers may event […]
  • Premature birth interrupts vital brain development processes leading to reduced cognitive abilities in infants May 20, 2013
    Researchers have for the first time used a novel form of MRI to identify crucial developmental processes in the brain that are vulnerable to the effects of premature birth. This new study shows that disruption of these specific processes can have an impact on cognitive function. […]
  • For combat veterans suffering from post-traumatic stress disorder, 'fear circuitry' in the brain never rests May 18, 2013
    Chronic trauma can inflict lasting damage to brain regions associated with fear and anxiety. Previous imaging studies of people with post-traumatic stress disorder, or PTSD, have shown that these brain regions can over-or under-react in response to stressful tasks. […]
  • Breakthrough for IVF? Selecting the most promising embryos May 17, 2013
    A recent study on 5-day old human blastocysts shows that those with an abnormal chromosomal composition can be identified by the rate at which they have developed to blastocysts, thereby classifying the risk of genetic abnormality without a biopsy. Now, researchers have undertaken a retrospective study, using their predictive model to assess the likelihood o […]
  • Fishing for memories: How long-term memories are processed to guide behavior May 16, 2013
    In our interaction with our environment we constantly refer to past experiences stored as memories to guide behavioral decisions. But how memories are formed, stored and then retrieved to assist decision-making remains a mystery. By observing whole-brain activity in live zebrafish, researchers have visualized for the first time how information stored as long […]

News Items

Links